February 6, 2017
Ablynx submits its thrombosis antibody to EMA
Ablynx has applied its caplacizumab to European Medicines Agency for approval to use it for a form of blod clotting disorder.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: thrombosis
September 25, 2015
Bayer: Factor Xa inhibitor Xarelto approved in Japan
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved in Japan Bayer’s oral Factor Xa inhibitor Xarelto (rivaroxaban) for the treatment…